Variability of definition of high‐risk multiple myeloma across phase III clinical trials
暂无分享,去创建一个
F. Zhan | M. Zangari | J. Shaughnessy | F. van Rhee | S. Thanendrarajan | C. Schinke | Samer Al Hadidi | O. Ababneh | Faris J Abu Za'nouneh
暂无分享,去创建一个
F. Zhan | M. Zangari | J. Shaughnessy | F. van Rhee | S. Thanendrarajan | C. Schinke | Samer Al Hadidi | O. Ababneh | Faris J Abu Za'nouneh